Journal of Antimicrobial Chemotherapy (2001) 47, 455-458
© 2001 The British Society for Antimicrobial Chemotherapy
Brief report |
In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula
a Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430; b Department of Clinical Investigation, US Naval Medical Research Unit No. 3, PSC 452, Box 5000, FPO AE 09835; c Central Research Division, Pfizer, Inc., Eastern Point Road, Groton, CT 06340 USA; d Bureau of Microbiology, HPB Bld 7, Locator 0701F1, Ottawa, Canada KIA 0L2
To explain good clinical results of azithromycin in patients with typhoid fever, 10 strains of Salmonella typhi were grown in cation-adjusted MuellerHinton broth. MICs of azithromycin were 416 mg/L. At a sub-MIC of 2 mg/L, early inhibition of growth was shown at 2, 4 and 8 h of incubation, but at 24 and 48 h growth to turbidity occurred. At 4 mg/L, inhibition occurred up to 8 h, after which growth towards turbidity followed. Elongated curved bacilli formed in broth containing 4 mg/L after 2448 h. Adjusting the pH of the broth with phosphate-citrate buffer to 7.5 and 8.0 caused reductions in MICs to 0.250.5 mg/L. Large inocula of 106 cfu/mL resulted in median MICs four- to six-fold greater than with inocula of 101103 cfu/mL. An inoculum of 10 bacteria per mL in broth at pH 7.5 resulted in an MIC of 0.13 mg/L. Clinical benefits in patients may occur because of early inhibition by sub-MIC concentrations of azithromycin, and due to lower MICs at alkaline pH and lower MICs with small inocula that may correspond to the low-grade bacteraemia in typhoid fever.
* Corresponding author. Tel: +1-806-743-3155; Fax: +1-806-743-3148; E-mail: medtcb{at}ttuhsc.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. M. Parry, V. A. Ho, L. T. Phuong, P. V. B. Bay, M. N. Lanh, L. T. Tung, N. T. H. Tham, J. Wain, T. T. Hien, and J. J. Farrar Randomized Controlled Comparison of Ofloxacin, Azithromycin, and an Ofloxacin-Azithromycin Combination for Treatment of Multidrug-Resistant and Nalidixic Acid-Resistant Typhoid Fever Antimicrob. Agents Chemother., March 1, 2007; 51(3): 819 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Giotis, D. A. McDowell, I. S. Blair, and B. J. Wilkinson Role of Branched-Chain Fatty Acids in pH Stress Tolerance in Listeria monocytogenes Appl. Envir. Microbiol., February 1, 2007; 73(3): 997 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. S. McMahon, J. Xu, J. E. Moore, I. S. Blair, and D. A. McDowell Environmental Stress and Antibiotic Resistance in Food-Related Pathogens Appl. Envir. Microbiol., January 1, 2007; 73(1): 211 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Butler Reduction of MIC of azithromycin for Salmonella typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella typhi J. Antimicrob. Chemother., July 1, 2002; 50(1): 143 - 145. [Full Text] [PDF] |
||||
![]() |
T. Butler Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics J. Antimicrob. Chemother., December 1, 2001; 48(6): 903 - 906. [Abstract] [Full Text] [PDF] |
||||


